Financial Gravity Asset Management’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-4
| Closed | -$359 | – | 1970 |
|
|
2023
Q4 | $359 | Buy |
4
+2
| +100% | +$180 | ﹤0.01% | 1195 |
|
|
2023
Q3 | $147 | Sell |
2
-87
| -98% | -$6.4K | ﹤0.01% | 984 |
|
|
2023
Q2 | $47 | Sell |
89
-18
| -17% | -$10 | ﹤0.01% | 1403 |
|
|
2023
Q1 | $181 | Sell |
107
-15
| -12% | -$25 | 0.01% | 634 |
|
|
2022
Q4 | $35 | Sell |
122
-187
| -61% | -$54 | ﹤0.01% | 1266 |
|
|
2022
Q3 | $175 | Buy |
309
+30
| +11% | +$17 | 0.01% | 571 |
|
|
2022
Q2 | $156 | Sell |
279
-72
| -21% | -$40 | ﹤0.01% | 559 |
|
|
2022
Q1 | $198 | Sell |
351
-3,564
| -91% | -$2.01K | 0.01% | 573 |
|
|
2021
Q4 | $3.64K | Buy |
3,915
+3,888
| +14,400% | +$3.62K | 0.08% | 239 |
|
|
2021
Q3 | $159K | Buy |
+27
| New | +$159K | 0.07% | 232 |
|
|
2020
Q1 | – | Sell |
-326
| Closed | -$139K | – | 1123 |
|
|
2019
Q4 | $139K | Sell |
326
-279
| -46% | -$119K | 0.1% | 208 |
|
|
2019
Q3 | $58K | Sell |
605
-261
| -30% | -$25K | 0.05% | 267 |
|
|
2019
Q2 | $100K | Sell |
866
-267
| -24% | -$30.8K | 0.08% | 227 |
|
|
2019
Q1 | $128K | Buy |
+1,133
| New | +$128K | 0.1% | 181 |
|
|
2018
Q3 | $0 | Hold |
2
| – | – | ﹤0.01% | 1383 |
|
|
2018
Q2 | $0 | Sell |
2
-1
| -33% | – | ﹤0.01% | 1405 |
|
|
2018
Q1 | $0 | Buy |
+3
| New | – | ﹤0.01% | 1388 |
|